Vivo Capital, LLC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 195 filers reported holding DYNE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.30 and the average weighting 0.9%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$57,703,949
+24.3%
1,635,1360.0%5.33%
+46.1%
Q1 2024$46,421,511
+237.2%
1,635,136
+58.0%
3.65%
+223.7%
Q4 2023$13,767,309
+48.4%
1,035,1360.0%1.13%
+10.9%
Q3 2023$9,274,819
+42.7%
1,035,136
+79.2%
1.02%
+126.3%
Q2 2023$6,498,473
-2.3%
577,6420.0%0.45%
-2.8%
Q1 2023$6,654,436
+99294.1%
577,6420.0%0.46%
-40.1%
Q4 2022$6,695
-99.9%
577,6420.0%0.77%
-4.8%
Q3 2022$7,336,000
+84.9%
577,6420.0%0.81%
+103.5%
Q2 2022$3,968,000
-28.7%
577,6420.0%0.40%
+3.9%
Q1 2022$5,568,000
-18.9%
577,6420.0%0.38%
-7.5%
Q4 2021$6,868,000
-26.8%
577,6420.0%0.41%
-1.7%
Q3 2021$9,381,000
-22.8%
577,6420.0%0.42%
-20.0%
Q2 2021$12,154,000
+35.5%
577,6420.0%0.53%
+67.0%
Q1 2021$8,971,000
+35.6%
577,642
+83.4%
0.32%
+6.8%
Q4 2020$6,615,000
+4.0%
315,0000.0%0.30%
-19.8%
Q3 2020$6,360,000315,0000.37%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,220,034$25,574,79234.99%
MPM ASSET MANAGEMENT LLC 4,951,303$57,039,01123.77%
Atlas Venture Life Science Advisors, LLC 9,885,449$113,880,37215.42%
TCG Crossover Management, LLC 1,650,150$19,009,7283.70%
Logos Global Management LP 1,700,000$19,584,0002.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 433,751$4,988,1371.39%
Octagon Capital Advisors LP 692,945$7,982,7261.15%
Deep Track Capital, LP 2,334,633$26,894,9721.10%
Altium Capital Management LP 155,000$1,785,6000.99%
HighVista Strategies LLC 102,431$1,180,0050.96%
View complete list of DYNE THERAPEUTICS INC shareholders